323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."

Episode metadata supplied by the publisher feed · Published Sep 19, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

323: Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

0:00 35:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 35 minutes long.

When was this The Readout Loud episode published?

This episode was published on September 19, 2024.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!